The University of Oklahoma Health Science Center

Oklahoma City, Oklahoma 73104

Use our guide to learn which trials are right for you!

We've found
8 trials
at this facility
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling, Phase
Updated: 12/31/1969
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
TODAY2 Phase 2 Follow-up
Status: Enrolling, Phase
Updated: 2/28/2018
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Femoropopliteal In-stent Restenosis Clinical Trial
JetStream Atherectomy for the Treatment of In-stent Restenosis
Status: Enrolling
Updated: 4/10/2018
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Oncology Clinical Trial
Expanded Access Protocol for GBM Patients With Already Manufactured DCVax®-L Who Have Screen-Failed Protocol 020221
Status: Enrolling
Updated: 2/25/2016
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Oncology Clinical Trial
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Oncology Clinical Trial
Expanded Access Study of Fenretinide Lym-X-Sorb Plus Ketoconazole in Neuroblastoma
Status: Enrolling
Updated: 4/12/2016
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Cystic Fibrosis Clinical Trial
Human Factors Study to Validate the User Interface of TOBI Podhaler Using Placebo Capsules
Status: Enrolling, Phase IV
Updated: 12/31/1969
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Carcinoma, Hepatocellular Clinical Trial
Safety and Efficacy of Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) Versus Lenvatinib as First-line Therapy in Participants With Advanced Hepatocellular Carcinoma (MK-7902-002/E7080-G000-311/LEAP-002)
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Oklahoma City, OK
Click here to add this to my saved trials